Redox International Group Corp
Redox International Group Corp is a biotechnology company that operates within the healthcare facilities and services industry, primarily generating revenue through its healthcare services and equipment offerings.
Business. Redox International Group Corp (ITOR.PK) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in the United States, the company is listed on the OTC market under the ticker symbol ITOR.PK. Specific details regarding operating segments and geographic presence are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Redox International Group Corp (ITOR.PK) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in the United States, the company is listed on the OTC market under the ticker symbol ITOR.PK. Specific details regarding operating segments and geographic presence are not disclosed in the available data.
Redox International Group Corp has a highly leveraged capital structure, with total liabilities of $30,480 million and total equity of -$25,010 million, resulting in a negative debt-to-equity ratio of -0.36. The company's liquidity position is weak, as evidenced by a current ratio of 0.06, indicating that it has only $0.06 in current assets for every $1 of current liabilities. The operating cash flow of -$16,780 million further highlights the company's cash flow challenges, which could limit its ability to meet short-term obligations.
Profitability metrics are severely negative, with a net income of -$3,620 million and an operating income of -$3,620 million, indicating that the company is not generating positive earnings from its core operations. The return on equity of 14.47% is misleading due to the negative equity base, and the return on assets of -6.61% suggests that the company is not effectively utilizing its assets to generate profit. These figures are well below the industry median for profitability metrics, which typically show positive returns for companies in the healthcare services and equipment sector.
The company's revenue of $1,600 million is relatively small compared to its liabilities and equity, and there is no detailed breakdown of revenue by segment or geography in the provided data. This lack of segmentation makes it difficult to assess the company's exposure to different markets or product lines. However, the negative equity and high debt levels suggest that the company may be heavily reliant on a few key markets or products, which could increase its vulnerability to market fluctuations.
The company's growth trajectory is uncertain, as there is no clear indication of revenue growth in the provided data. The negative operating cash flow and net income suggest that the company is not in a position to sustain growth without external financing. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the key flag of negative net cash after subtracting total debt highlights the company's financial instability. The dilution potential is low, but the company may need to issue additional shares to raise capital, which could dilute existing shareholders' equity.
Recent events and filings have not been provided in the input data, so it is not possible to assess the company's recent performance or strategic initiatives. However, the financial snapshot suggests that the company is facing significant financial challenges that may require restructuring or additional financing to address.
The company's risk profile is dominated by liquidity and solvency concerns, with a negative equity position and high debt levels. The risk assessment indicates a medium liquidity risk, which is consistent with the company's weak current ratio and negative operating cash flow. The credit risk is also high due to the company's inability to generate positive cash flow and its reliance on debt financing. The dilution risk is currently low, but the company may need to issue additional shares to raise capital, which could increase the dilution risk in the future.
- Redox International Group Corp has a highly leveraged capital structure with a negative debt-to-equity ratio of -0.36.
- The company is not generating positive earnings, with a net income and operating income of -$3,620 million.
- The company's liquidity position is weak, as indicated by a current ratio of 0.06 and a negative operating cash flow of -$16,780 million.
- The company's return on equity is 14.47%, but this is misleading due to the negative equity base.
- The company's financial stability is at risk due to its high debt levels and negative equity position.
- The company may need to issue additional shares to raise capital, which could dilute existing shareholders' equity.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- Redox International Group Corp Market data — financials · 2026-05-28